AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Pharmarise Holdings Corporation
  3. Financials
  4. Total liabilities

Pharmarise Holdings Corporation【JP:2796】

Market cap
¥6.2B
P/E ratio
21.8x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
May 31, 202525,005+13.44%
May 31, 202422,043+34.14%
May 31, 202316,433-3.60%
May 31, 202217,047-7.31%
May 31, 202118,392-4.50%
May 31, 202019,259+3.56%
May 31, 201918,597-0.23%
May 31, 201818,640+0.01%
May 31, 201718,639-4.07%
May 31, 201619,430+5.51%
May 31, 201518,415-4.34%
May 31, 201419,251

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)